Bullish Moving Averages
11
Bearish Moving Averages
5
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
241.00Today’s High
258.0052W low
196.1052W High
472.80Open Price
242.90Prev. Close
219.8500Volume
2525383.00Value
634957047.69Fundamentals
Market Cap
8159.40
Price to Earnings
-21.00
Price to Book Value
65.40
Dividend Yield
0.00
PE to Growth
0.30
Op Revenue TTM
75.55
Net Profit TTM
-388.11
Cash From Operating Activity
-429.43
Return on Equity %
-310.86
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
05 Jul, 2024
48.3
Week
52.7
Month
53.6
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
250.15
PIVOT
First Resistance
259.28
Second Resistance
267.14
Third Resistance
276.27
First Support
242.29
Second Support
233.16
Third Support
225.30
Relative Strength Index
61.95
Money Flow Index
63
MACD
3.33
MACD Signal
1.32
Average True Range
10.18
Average Directional Index
22.5
Rate of Change (21)
19.73
Rate of Change (125)
-35.07
Commodity Channel Index
142.1
Williams %R
-23.3
BETA
1 Month
0.88
3 Month
1.05
1 Year
0.75
3 Year
0.35
PRICE CHANGE ANALYSIS
↑ 2.69%
1 Week
Low
High
233.1
258
↑ 23.61%
1 Month
Low
High
196.1
258
↓ -39.12%
3 Months
Low
High
196.1
472.8
↓ -34.68%
6 Months
Low
High
196.1
472.8
↑ 22.2%
1 Year
Low
High
196.1
472.8
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 20.96 | 20.25 | 29.67 | 34.14 | 58.42 | 131.12 | 31.60 | 28.64 | 25.46 | 62.49 | 33.85 | |
| Operating Expenses Qtr | 124.08 | 116.48 | 112.65 | 126.13 | 137.26 | 114.91 | 94.14 | 106.66 | 91.78 | 73.42 | 83.04 | |
| Operating Profit Qtr | -107.52 | -102.62 | -91.47 | -102.18 | -89.57 | 16.18 | -62.60 | -78.20 | -66.54 | -11.27 | -55.17 | |
| EBIDT Qtr Cr | -103.12 | -96.23 | -82.98 | -91.99 | -78.84 | 16.21 | -62.54 | -78.02 | -66.32 | -10.93 | -49.19 | |
| Depreciation Qtr | 2.69 | 3.16 | 3.18 | 3.10 | 2.94 | 3.13 | 3.00 | 2.70 | 2.51 | 2.58 | 2.54 | |
| Net Profit Qtr | -106.69 | -99.65 | -86.42 | -95.35 | -81.99 | 10.15 | -68.40 | -82.35 | -71.05 | -15.84 | -55.14 | |
| Basic EPS Qtr | -3.29 | -3.07 | -2.66 | -2.94 | -2.55 | 0.37 | -2.52 | -3.03 | -2.69 | -0.60 | -2.09 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 105.02 | 249.66 | 144.09 | 258.37 | 86.58 | |
| Operating Expenses Annual Cr | 479.34 | 452.84 | 324.00 | 387.93 | 386.83 | |
| Operating Profit Annual | -403.79 | -214.06 | -186.75 | -134.98 | -310.01 | |
| Operating Profit Margin Annual % | -384.49 | -85.74 | -129.60 | -52.24 | -358.07 | |
| Total Expenses Annual Cr | 493.13 | 472.24 | 347.49 | 409.51 | 398.98 | |
| EBIDT Annual Cr | -374.32 | -203.18 | -179.90 | -129.57 | -300.25 | |
| EBIDT Annual margin % | -356.43 | -81.38 | -124.85 | -50.15 | -346.80 | |
| Depreciation | 12.13 | 11.77 | 10.16 | 10.92 | 9.48 | |
| PAT Before ExtraOrdinary Items Annual Cr | -388.11 | -222.58 | -203.40 | -151.14 | -312.40 | |
| Net Profit Annual | -388.11 | -222.58 | -203.40 | -151.14 | -312.40 | |
| Basic EPS Annual | -11.96 | -7.82 | -7.73 | -5.77 | -11.92 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 124.85 | 512.78 | 31.23 | -168.25 | -18.64 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 117.59 | 138.41 | 77.43 | 164.59 | 55.85 | |
| Total Current Liabilities Annual Cr | 243.89 | 178.95 | 171.43 | 233.35 | 235.36 | |
| Total Capital Plus Liabilities Annual Cr | 486.33 | 830.13 | 280.08 | 229.69 | 272.56 | |
| Fixed Assets Annual | 146.44 | 132.75 | 118.23 | 95.79 | 135.93 | |
| Total Non Current Assets Annual | 239.93 | 375.16 | 208.93 | 166.58 | 205.38 | |
| Total Current Assets Annual | 246.40 | 454.96 | 71.15 | 63.11 | 67.19 | |
| Total Assets Annual | 486.33 | 830.13 | 280.08 | 229.69 | 272.56 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 84.97 | 167.13 | 95.28 | 95.62 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | -429.43 | -69.12 | -208.23 | -151.90 | -210.81 | |
| Cash from Investing Activity Annual | 391.11 | -548.28 | -29.17 | 1.56 | 155.35 | |
| Cash from Financing Annual Activity | 42.80 | 616.76 | 229.32 | 159.28 | 55.46 | |
| Net Cash Flow Annual | 4.48 | -0.64 | -8.08 | 8.95 | 0.00 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 3.85 | 15.80 | 1.15 | -6.42 | -0.71 | |
| ROE Annual % | -310.86 | -43.40 | -651.37 | 0.00 | 0.00 | |
| ROCE Annual % | -159.40 | -33.00 | -174.92 | 3836.49 | -832.42 | |
| Total Debt to Total Equity Annual | 0.38 | 0.00 | 2.40 | -1.17 | -3.64 | |
| EBDIT Annual Margin % | -495.45 | -85.09 | -131.07 | -51.22 | -390.87 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Graph |
|---|---|---|---|---|---|
| Total Qtr Revenue cr | 20.96 | 20.25 | 29.67 | 34.14 | |
| Operating Expenses Qtr | 122.39 | 116.48 | 112.65 | 126.13 | |
| Operating Profit Qtr | -105.83 | -102.62 | -91.47 | -102.18 | |
| EBIDT Qtr Cr | -101.43 | -96.23 | -82.98 | -91.99 | |
| Depreciation Qtr | 3.07 | 3.16 | 3.18 | 3.10 | |
| Net Profit Qtr | -105.79 | -99.65 | -86.42 | -95.35 | |
| Basic EPS Qtr | -3.26 | -3.07 | -2.66 | -2.94 |
| Indicator | Mar 2024 | Graph |
|---|---|---|
| Total Revenue Annual | 105.02 | |
| Operating Expenses Annual Cr | 477.65 | |
| Operating Profit Annual | -402.10 | |
| Operating Profit Margin Annual % | -382.88 | |
| Total Expenses Annual Cr | 491.85 | |
| EBIDT Annual Cr | -372.63 | |
| EBIDT Annual margin % | -354.82 | |
| Depreciation | 12.51 | |
| PAT Before ExtraOrdinary Items Annual Cr | -387.21 | |
| Net Profit Annual | -387.21 | |
| Basic EPS Annual | -11.93 |
| Indicator | Mar 2024 | Graph |
|---|---|---|
| Total ShareHolders Funds Annual | 125.75 | |
| Minority Interest Liability Annual Cr | 0.00 | |
| Total Non Current Liabilities Annual Cr | 124.24 | |
| Total Current Liabilities Annual Cr | 265.05 | |
| Total Capital Plus Liabilities Annual Cr | 515.04 | |
| Fixed Assets Annual | 151.33 | |
| Total Non Current Assets Annual | 245.66 | |
| Total Current Assets Annual | 269.38 | |
| Total Assets Annual | 515.04 | |
| Contingent Liabilities plus Commitments Annual Cr | - |
| Indicator | Mar 2024 | Graph |
|---|---|---|
| Cash from Operating Activity Annual | -429.20 | |
| Cash from Investing Activity Annual | 391.53 | |
| Cash from Financing Annual Activity | 42.42 | |
| Net Cash Flow Annual | 4.75 |
| Indicator | Mar 2024 | Graph |
|---|---|---|
| Book Value Per Share Annual | 3.88 | |
| ROE Annual % | -307.92 | |
| ROCE Annual % | -154.06 | |
| Total Debt to Total Equity Annual | 0.37 | |
| EBDIT Annual Margin % | -493.22 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Enam Securities Private Limited | 1.04 | 74504402 | - | - |
| Jhunjhunwala Rekha Rakesh | 1.94 | 74504405 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Dilip Shantilal Shanghvi | 19.05 | 74504369 | 0 | 54.53 |
| Sudhir Valia | 0.57 | 74504370 | 98.15 | 0 |
| Shanghvi Finance Private Limited | 42.28 | 74504376 | 0 | 0 |
| Aditya Medisales Limited | 1.51 | 74504377 | 0 | 0 |
| Raksha S.Valia | 1.28 | 74504378 | 99.39 | 0 |
| Name | Holding Percent | Holding Id |
|---|
| Name | Holding Percent | Holding Id |
|---|---|---|
| Jhunjhunwala Rekha Rakesh | 1.94 | 74504405 |
| Vijay Mohanlal Parekh | 1.13 | 74504406 |
| Paresh Mohanlal Parekh | 1.12 | 74504407 |
| HUF | 0.66 | 74504394 |
| Clearing Members | 0.55 | 74504395 |
| Lakshdeep Investments & Finance (P) Ltd. | 1.58 | 74504401 |
| Enam Securities Private Limited | 1.04 | 74504402 |
| Sun Pharmaceutical Industries Key Employees Benefit Trust | 3.18 | 74504412 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 24, 2024 | Audited Results | - |
| Feb 05, 2024 | Quarterly Results | - |
| Nov 06, 2023 | Quarterly Results | - |
| Aug 07, 2023 | Quarterly Results | - |
| May 22, 2023 | Audited Results & Others | To consider Fund Raising |
| Feb 13, 2023 | Quarterly Results | - |
| Nov 07, 2022 | Quarterly Results | - |
| Aug 08, 2022 | Quarterly Results & Others | Inter alia, to consider and evaluate various options or proposals for raising funds through any of the permissible modes, subject to the receipt of necessary approvals. |
| May 17, 2022 | Audited Results | - |
| Feb 04, 2022 | Quarterly Results | - |
| Nov 01, 2021 | Quarterly Results | - |
| Sep 01, 2021 | Others | inter alia, to consider and approve / evaluate various options or proposals for raising funds through any of the permissible modes, subject to the receipt of necessary approvals. |
| Jul 26, 2021 | Quarterly Results | - |
| May 17, 2021 | Audited Results | - |
| May 12, 2021 | Others | Inter alia, to consider and evaluate proposals for raising of funds in one or more tranches by way of issue of Equity Shares or Securities/ Warrants convertible into Equity shares of the Company. |
| Feb 08, 2021 | Quarterly Results | - |
| Nov 09, 2020 | Quarterly Results | - |
| Aug 04, 2020 | Quarterly Results | - |
| Jun 02, 2020 | Audited Results | - |
| Jan 31, 2020 | Quarterly Results | - |
| Nov 04, 2019 | Quarterly Results | - |
| Jul 29, 2019 | Quarterly Results | - |
| May 07, 2019 | Audited Results | - |
| Feb 04, 2019 | Quarterly Results | - |
| Oct 29, 2018 | Quarterly Results | - |
| Jul 30, 2018 | Quarterly Results | - |
| May 08, 2018 | Audited Results | - |
| Jan 29, 2018 | Quarterly Results | - |
| Oct 27, 2017 | Quarterly Results | - |
| Aug 05, 2017 | Quarterly Results | - |
| Jul 14, 2017 | Others | Allotted 1,51,51,515 Warrants at a price (including the warrant subscription price and the warrant exercise price) of ` 330/- each. |
| May 05, 2017 | Others | - |
| Jan 27, 2017 | Quarterly Results | - |
| Oct 28, 2016 | Quarterly Results | - |
| Jul 29, 2016 | Quarterly Results | - |
| May 06, 2016 | Audited Results | - |
| Mar 05, 2016 | Others | To fix the Issue Price, Issue Size, Rights Entitlement Ratio, Fractional Entitlement & Record Date / Book Closure Dates for determining eligibility of the shareholders. |
| Feb 03, 2016 | Quarterly Results | - |
| Nov 04, 2015 | Quarterly Results & Others | approved the re-appointment of Mr. Sudhir Valia as the Director & CFO of the Company, who retires as a CFO on December 31, 2015, |
| Aug 01, 2015 | Quarterly Results | - |
| May 12, 2015 | Rights Issue | To consider the issue of equity shares of Re.1 each of the Company by way of rights issue for raising the funds for the Company. |
| May 05, 2015 | Audited Results | - |
| Jan 30, 2015 | Quarterly Results | - |
| Oct 31, 2014 | Quarterly Results | - |
| Jul 31, 2014 | Quarterly Results | - |
| May 03, 2014 | Audited Results | - |
| Feb 01, 2014 | Quarterly Results | - |
| Oct 29, 2013 | Quarterly Results | - |
| Jul 30, 2013 | Quarterly Results | - |
| May 14, 2013 | Audited Results | - |
| Jan 24, 2013 | Quarterly Results | - |
| Oct 27, 2012 | Quarterly Results | - |
| Jul 31, 2012 | Quarterly Results | - |
| May 02, 2012 | Audited Results | - |
| Feb 01, 2012 | Quarterly Results | - |
| Oct 24, 2011 | Quarterly Results | - |
| Aug 08, 2011 | Quarterly Results | - |
| May 07, 2011 | Audited Results | - |
| Feb 01, 2011 | Quarterly Results | - |
| Oct 21, 2010 | Quarterly Results | - |
| Jul 24, 2010 | Quarterly Results | - |
| May 22, 2010 | Audited Results | - |
| Jan 23, 2010 | Quarterly Results | - |
| Oct 24, 2009 | Quarterly Results | - |
| Jul 20, 2009 | Quarterly Results | - |
| May 23, 2009 | Audited Results | - |
| Jan 24, 2009 | Quarterly Results | - |
| Oct 27, 2008 | Quarterly Results | - |
| Jul 29, 2008 | Quarterly Results | - |
| May 14, 2008 | Audited Results | - |
| Jan 24, 2008 | Quarterly Results | - |
| Oct 27, 2007 | Quarterly Results | - |
| Jul 23, 2007 | Quarterly Results | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
26 Jun 2024
SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Closure of Trading Window
Intimation regarding closure of Trading Window 
24 May 2024
SPARC Board Proposes To Raise Rs 1,800 Crore
The research company is looking to issue securities in one or more tranches through modes approved by the law.
24 May 2024
SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Board Meeting Outcome for Board Meeting Outcome For Audited Financial Results
Outcome for Board Meeting
24 May 2024
SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Board Meeting Outcome For Audited Financial Results.
Outcome of Board Meeting
